Advancement-stage cancers (Group III) showed a higher prevalence of theC2 IGFBP3+ and C3 HHATL+ subtypes, with IGFBP3 being linked to apoptosis resistance and HHATL-mediated hedgehog signaling, which might increase stemness. The gene discussed is IGFBP3; the disease is cancer.